KalVista Showcases EKTERLY® Data Demonstrating Transformative Potential in HAE Treatment

KalVista Pharmaceuticals Highlights EKTERLY® (Sebetralstat) as a Transformative Oral On-Demand Therapy for Hereditary Angioedema in Europe KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), a clinical-stage biotechnology company focused on developing innovative therapies…

Read MoreKalVista Showcases EKTERLY® Data Demonstrating Transformative Potential in HAE Treatment

BUILT Biotechnologies Named Anchor Company at Commonwealth BioAccelerator Amid DNA Manufacturing Growth

BUILT Biotechnologies Named Anchor Company at Commonwealth BioAccelerator, Scaling DNA Manufacturing-as-a-Service to Meet Surging Demand BUILT Biotechnologies,a rapidly emerging leader in DNA Manufacturing-as-a-Service, has announced its selection as an anchor…

Read MoreBUILT Biotechnologies Named Anchor Company at Commonwealth BioAccelerator Amid DNA Manufacturing Growth